R Squared’s Aehr Test Systems AEHR Stock Holding History

R Squared’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-570	Closed	-$9.48K	–	313
2024 Q4	$9.48K	Buy	+570	New	+$7.6K	0.01%	1169

Other funds holding AEHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HFF

Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

R Squared's AEHR Position: Q1 2025 in Review

R Squared sold out of Aehr Test Systems (AEHR) in Q1 2025, closing a stake of 570 shares — an estimated $9.48K sold.

R Squared first reported a position in AEHR in Q4 2024 and held it in 1 quarter. The position peaked at $9.48K in Q4 2024. 115 funds tracked by Wall St. Rank hold AEHR as of Q1 2025.

R Squared reported no remaining Aehr Test Systems position as of Q1 2025 after selling out during the quarter.
R Squared sold 570 Aehr Test Systems shares in Q1 2025, an estimated $9.48K.
R Squared first reported a position in Aehr Test Systems in Q4 2024 and held it in 1 quarter.
R Squared's Aehr Test Systems position peaked at $9.48K in Q4 2024.
115 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.